SGMT CIK: 1400118

Sagimet Biosciences Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
−24.5
FY23:
−23.8
FY24:
−42.4
FY25:
−45.7
millions USD
FY21:
0
FY22:
−32.0
FY23:
12.6
FY24:
−61.7
FY25:
4.56
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
−0.07
FY23:
86.2
FY24:
105
FY25:
0.28

All amounts in millions USD FY21: figures supplemented from Twelve Data because the SEC filings do not reach back this far. Data sources:SEC EDGARTwelve Data